Clinical trials: Antiretroviral Treatment Outcomes, open to volunteers
Metabolic Syndrome, Obesity & Overweight
Effect of Empagliflozin on Metabolic Outcomes in Adults Living With HIV Receiving Dolutegravir-Based Therapy
We investigate the role of empagliflozin in the treatment of obesity in PLWH.
- Conditions
- Metabolic Syndrome, Obesity & Overweight, HIV (Human Immunodeficiency Virus)
- Trial name
- NCT07336797
- Testing
- Empagliflozin (oral)
- Where
- Egypt
- Volunteers
- 66 people
- Sponsor
- Abdelrahman Mahmoud
HIV (Human Immunodeficiency Virus), Sleep
Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in People Living With HIV
In South Africa, antiretroviral therapy (ART) has transformed HIV into a chronic, manageable condition, with high rates of viral suppression.
- Trial name
- SOMNART (NCT07673965)
- Testing
- Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Doravirine 100mg, Tenofovir disoproxil fumarate 300mg / Lamivudine 300mg / Dolutegravir 50mg
- Volunteers
- 40 people
- Sponsor
- University of Witwatersrand, South Africa
Pregnant HIV Positive Women
Effect of Omega-3 Supplementation on Pregnant Outcomes and Inflammation Markers of Women Infected With HIV Using Antiretroviral Therapy
This clinical trial aims to determine the effect of PUFA-n3 supplementation on birth weight, gestational length, and plasma inflammatory markers in pregnant women with HIV who are on antiretroviral therapy.
- Trial name
- OM3HIVPROUTINF (NCT06971445)
- Testing
- omega-3 polyunsaturated fatty acids (PUFA n-3)
- Where
- Mexico
- Volunteers
- 92 people
- Sponsor
- Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes
HIV Infections
The Antiretroviral Speed Access Program Switch (ASAP-Switch) Study
This project builds on our experience with the ASAP Study (McGill University Health Centre research ethics board: MP-37-2020-4911).
- Trial name
- NCT06375304
- Testing
- B/F/TAF
- Where
- Canada
- Volunteers
- 50 people
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
HIV Antiretroviral Therapy (ART) Adherence, Alcohol Consumption
Pilot of an Intervention to Reduce Alcohol Use and Improve ART Adherence Among Men Living With HIV With Pregnant Partners in Uganda.
Hazardous alcohol use, which is common among men in Uganda, is a primary driver of both HIV risk and intimate partner violence (IPV) in this setting.
- Trial name
- Kisoboka Amaka (NCT06900634)
- Testing
- Kisoboka Amaka, Screening and Referral
- Where
- Uganda
- Volunteers
- 60 people
- Sponsor
- San Diego State University
HIV
Post Analytic Treatment Interruption Study
This exploratory study is designed to ensure the safety of HIV-infected volunteers who complete research protocols that include an analytic treatment interruption (ATI).
- Trial name
- NCT02761200
- Where
- Thailand
- Volunteers
- 100 people
- Sponsor
- SEARCH Research Foundation
HIV, HIV Antiretroviral Therapy (ART) Adherence
Transitional Housing and HIV Health
The goal of this pilot study is to evaluate the implementation and outcomes of the Arms Around You (AAY) program, a supportive housing initiative launched by the Philadelphia Department of Public Health (PDPH) in 2024.
- Conditions
- HIV, HIV Antiretroviral Therapy (ART) Adherence, Housing Instability
- Trial name
- NCT06829394
- Testing
- Program Assignment
- Where
- 2 sites in United States
- Volunteers
- 200 people
- Sponsor
- University of Pennsylvania